5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 Dapagliflozin Intermediate Factory

Lus piav qhia luv luv:

Lub npe: 5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane

Cov ntsiab lus: 4-Bromo-1-Chloro-2-(4-Ethoxybenzyl) benzene

CAS: 461432-23-5 Nr

Purity: ≥99.0% (HPLC)

Cov tsos mob: Dawb rau Pael Yellow Crystalline Hmoov

Intermediate ntawm Dapagliflozin (CAS: 461432-26-8) hauv kev kho mob ntshav qab zib hom II

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chemical Properties:

Tshuaj npe 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane
Synonyms 4-Bromo-1-Chloro-2-(4-Ethoxybenzyl) benzene;4-(5-Brom-2-Chlorbenzyl) phenyl-Ethylether;Dapagliflozin Bromo impurity
CAS Nr 461432-23-5
CAT Number Qauv: RF-PI447
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C15H14BrClO
Molecular Luj 325.63 ib
Melting Point 41.0 txog 43.0 ℃
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Dawb rau Pael Yellow Crystalline Hmoov
Purity / Analysis Method ≥99.0% (HPLC)
Dej (KF) ≤0.50%
Tag nrho cov impurities ≤ 1.0%
Test Standard Enterprise Standard
Kev siv Intermediate of Dapagliflozin (CAS: 461432-26-8), type II diabetes

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard Nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.

Qhov zoo:

1

FAQ:

Daim ntawv thov:

4-Bromo-1-Chloro-2-(4-Ethoxybenzyl) benzene (CAS: 461432-23-5) yog siv los ua ib qho nruab nrab hauv kev sib xyaw ntawm Dapagliflozin (CAS: 461432-26-8).Dapagliflozin yog ib qho muaj zog, xaiv lub raum sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor rau kev kho mob ntshav qab zib hom 2.Dapagliflozin yog ib qho tshuaj tiv thaiv kab mob tshiab uas koom ua ke tsim los ntawm Bristol-Myers Squibb thiab AstraZeneca, tau pom zoo los ntawm European Medicines Agency (EMA) thaum lub Kaum Ib Hlis 12, 2012. Lub Ib Hlis 8, 2014, US Food and Drug Administration (FDA) tau pom zoo. siv rau kev kho mob ntshav qab zib hom II.

Sau koj cov lus ntawm no thiab xa tuaj rau peb